Stage II trial from weekly irinotecan/cisplatin for the advanced esophageal disease

Stage II trial from weekly irinotecan/cisplatin for the advanced esophageal disease Di Lauro L, Fattoruso Lorsque, Giacinti L, ainsi que al. Second-line chemo having FOLFIRI from inside the patients with metastatic gastric cancer tumors (MGC) not in the past addressed with fluoropyrimidines. J Clin Oncol. 2009. s (suppl; abstr 4549). Burtness B, Gibson M, Egleston B, mais aussi al. Stage II demonstration away from docetaxel-irinotecan consolidation in the complex esophageal malignant tumors. Ann Oncol. 2009 Jul. 20(7):1242-8. [QxMD MEDLINE Hook...

Read More